RNS Number : 1502M
DeepMatter Group PLC
20 May 2022
 

 


                                                                                                                                                

20 May 2022

 

DeepMatter extends Springer Nature relationship for a further three years

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, has renewed its long-term commercial relationship with Springer Nature ("Springer Nature"), a leading global research publisher for a further three years.

 

The Agreement is expected to generate revenues of at least €206,000 during the term.

 

DeepMatter licences proprietary algorithms and supports Springer Nature in handling proprietary data to accelerate and enhance discovery for its academic and industry customers. 

 

Mark Warne, CEO of DeepMatter, commented:

 

"Springer Nature is committed to supporting researchers in sharing research data and we are delighted to be working with them to provide products and services making sharing research data faster, easier and more impactful"

 

Dr. Cécile Mack, Managing Director Digital Products & Marketing (Springer Medizin) of Springer Nature, commented:

 

"In supporting the research community, we have found DeepMatter's products and services an excellent resource.  We are pleased to extend our long-term relationship and look forward to exploring the ways in which their technology and expertise can help us unlock further quality data."

 

For more information contact

 

DeepMatter Group Plc
Fraser Benson, Chief Financial Officer                                                                                     0141 548 8156


Canaccord Genuity Limited (Nominated Adviser and Broker)
                                          020 7523 8000
Bobbie Hilliam


Meare Consulting
                                                                                                                       07990 858548
Adrian Duffield

                 

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.  

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

About Springer Nature

 

For over 175 years Springer Nature has been advancing discovery by providing the best possible service to the whole research community. We help researchers uncover new ideas, make sure all the research we publish is significant, robust and stands up to objective scrutiny, that it reaches all relevant audiences in the best possible format, and can be discovered, accessed, used, re-used and shared. We support librarians and institutions with innovations in technology and data; and provide quality publishing support to societies. 

As a research publisher, Springer Nature is home to trusted brands including Springer, Nature Portfolio, BMC, Palgrave Macmillan and Scientific American.

 

For more information, please visit springernature.com and @SpringerNature

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTGPUGWAUPPGWB